RILUZOLE AND EXPERIMENTAL PARKINSONISM - ANTAGONISM OF MPTP-INDUCED DECREASE IN CENTRAL DOPAMINE LEVELS IN MICE

被引:57
作者
BOIREAU, A
DUBEDAT, P
BORDIER, F
PENY, C
MIQUET, JM
DURAND, G
MEUNIER, M
DOBLE, A
机构
[1] RhÚne-Poulenc Rorer S.A, Centre de Recherche de Vitry-Alfortville, Département Biologie, Vitry-sur-Seine, 94403
关键词
DOPAMINE; RILUZOLE; MPTP; EXCITOTOXICITY; PARKINSONS DISEASE;
D O I
10.1097/00001756-199412000-00063
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
WE have investigated whether riluzole, a compound that interferes with glutamatergic (GLUergic) transmission, would protect central dopaminergic (DAergic) neurones from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity in the striatum in mice. MPTP decreased DA, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels. Riluzole protected against the MPTP-induced decrease in DA levels. The utilization of DA ([DOPAC + HVA]/DA) was increased after MPTP treatment, but returned to control values in mice given riluzole in combination with MPTP. Riluzole did not confer protection by inhibiting either monoamine oxidase type B activity or DA uptake. Possible mechanisms involved in the protective action of riluzole are discussed. Our results show that riluzole antagonizes the DAergic neurotoxicity of MPTP, a pro-parkinsonian neurotoxin, in mice.
引用
收藏
页码:2657 / 2660
页数:4
相关论文
共 26 条
[1]
2-AMINO-6-TRIFLUOROMETHOXY BENZOTHIAZOLE, A POSSIBLE ANTAGONIST OF EXCITATORY AMINO-ACID NEUROTRANSMISSION .2. BIOCHEMICAL-PROPERTIES [J].
BENAVIDES, J ;
CAMELIN, JC ;
MITRANI, N ;
FLAMAND, F ;
UZAN, A ;
LEGRAND, JJ ;
GUEREMY, C ;
LEFUR, G .
NEUROPHARMACOLOGY, 1985, 24 (11) :1085-1092
[2]
RILUZOLE AND EXPERIMENTAL PARKINSONISM - PARTIAL ANTAGONISM OF MPP(+)-INDUCED INCREASE IN STRIATAL EXTRACELLULAR DOPAMINE IN RATS IN-VIVO [J].
BOIREAU, A ;
MIQUET, JM ;
DUBEDAT, P ;
MEUNIER, M ;
DOBLE, A .
NEUROREPORT, 1994, 5 (16) :2157-2160
[3]
NMDA ANTAGONISTS PARTIALLY PROTECT AGAINST MPTP INDUCED NEUROTOXICITY IN MICE [J].
BROUILLET, E ;
BEAL, MF .
NEUROREPORT, 1993, 4 (04) :387-390
[4]
A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[5]
CHAN P, 1993, J PHARMACOL EXP THER, V267, P1515
[6]
CORSINI GU, 1991, POSTERS NEUROSCI, V1, P33
[7]
CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254
[8]
DOPAMINERGIC NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE IN MICE [J].
HEIKKILA, RE ;
HESS, A ;
DUVOISIN, RC .
SCIENCE, 1984, 224 (4656) :1451-1453
[9]
HETIER E, 1988, N-S ARCH PHARMACOL, V337, P13
[10]
PARKINSONISM-INDUCING NEUROTOXIN, N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - UPTAKE OF THE METABOLITE N-METHYL-4-PHENYLPYRIDINE BY DOPAMINE NEURONS EXPLAINS SELECTIVE TOXICITY [J].
JAVITCH, JA ;
DAMATO, RJ ;
STRITTMATTER, SM ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (07) :2173-2177